Zheng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zheng Zhang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Bing Jiang
Department of Integrated Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, China
3 shared publicationsZheng Wang
Department of Integrated Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, China
3 shared publicationsHaixiang Su
Department of Integrated Chinese and Western Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, China
2 shared publicationsJin Xu
Department of Integrated Chinese and Western Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, China
2 shared publicationsLinlin Wang
Department of Integrated Chinese and Western Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, China
2 shared publicationsLongfei Feng
Department of Integrated Chinese and Western Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou, China
2 shared publications
Latest Publications
- Open Access
- 29 March 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1088575
The role of autophagy in cardiovascular disease: Cross-interference of signaling pathways and underlying therapeutic targets
Autophagy is a conserved lysosomal pathway for the degradation of cytoplasmic proteins and organelles, which realizes the metabolic needs of cells and the renewal of organelles. Autophagy-related genes (ATGs) are the main molecular mechanisms controlling autophagy, and their functions can coordinate the whole autophagic process. Autophagy can also play a role in cardiovascular disease through several key signaling pathways, including PI3K/Akt/mTOR, IGF/EGF, AMPK/mTOR, MAPKs, p53, Nrf2/p62, Wnt/β-catenin and NF-κB pathways. In this paper, we reviewed the signaling pathway of cross-interference between autophagy and cardiovascular diseases, and analyzed the development status of novel cardiovascular disease treatment by targeting the core molecular mechanism of autophagy as well as the critical signaling pathway. Induction or inhibition of autophagy through molecular mechanisms and signaling pathways can provide therapeutic benefits for patients. Meanwhile, we hope to provide a unique insight into cardiovascular treatment strategies by understanding the molecular mechanism and signaling pathway of crosstalk between autophagy and cardiovascular diseases.
- 29 March 2023
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 10, 1088575
Open AccessThe role of autophagy in cardiovascular disease: Cross-interference of signaling pathways and underlying therapeutic targets
Autophagy is a conserved lysosomal pathway for the degradation of cytoplasmic proteins and organelles, which realizes the metabolic needs of cells and the renewal of organelles. Autophagy-related genes (ATGs) are the main molecular mechanisms controlling autophagy, and their functions can coordinate the whole autophagic process. Autophagy can also play a role in cardiovascular disease through several key signaling pathways, including PI3K/Akt/mTOR, IGF/EGF, AMPK/mTOR, MAPKs, p53, Nrf2/p62, Wnt/β-catenin and NF-κB pathways. In this paper, we reviewed the signaling pathway of cross-interference between autophagy and cardiovascular diseases, and analyzed the development status of novel cardiovascular disease treatment by targeting the core molecular mechanism of autophagy as well as the critical signaling pathway. Induction or inhibition of autophagy through molecular mechanisms and signaling pathways can provide therapeutic benefits for patients. Meanwhile, we hope to provide a unique insight into cardiovascular treatment strategies by understanding the molecular mechanism and signaling pathway of crosstalk between autophagy and cardiovascular diseases.
- Open Access
- 30 November 2022
- Published by Springer Nature in Research Square
Network pharmacology and in vitro studies show the pharmacological effects and molecular mechanisms of salidroside against coronary artery disease
Background Salidroside (Sal) has many pharmacological effects, including anti-fatigue, anti-aging, immunoregulation and so on. However, its effects and related regulatory mechanisms on coronary artery disease (CAD) are elusive. We hypothesize that Sal may play a role in CAD through autophagic pathway. Herein, we used autophagy agonist (sirolimus, Sir) and inhibitor (chloroquine diphosphate, CQ) as the autophagic control group. And network pharmacology prediction was employed to explore the pharmacological effects and molecular mechanisms of Sal on CAD using network pharmacology prediction, and validated the results through in vitro experiments. Methods Through a search in the Swisstarget Prediction database, chemical composition and targets were retrieved. The related-autophagic targets for CAD were then obtained from the GEO and human autophagy databases. The network was constructed that depicted the interactions between putative drugs (Sal, Sir and CQ) and known related-autophagic targets for CAD using Cytoscape 3.8.0. Analysis of protein-protein interaction (PPI) was achieved via STRING software, followed by gene ontology (GO) functional enrichment and kyoto enrichment of gene and genome (KEGG) pathway analyses. The 3D structure of target protein was downloaded from RSCB PDB database, the 2D structure of drug was obtained from PubChem database, then the molecular docking was constructed by using AutoDockTools 1.5.6 and AutoDock Vina software, and the results were visualized by using PyMoL sofeware. To validate the computer-predicted results, in vitro experiments based on an anoxic injury model were designed by using CoCl2-exposed H9C2 cells, and treated with various concentrations of Sal/Sir/CQ. The effects of drugs on cells were detected by using the CCK-8, inverted microscope (IM), transmission electron microscope (TEM), MDC staining and AO staining. Moreover, the expression profiles of related-proteins were analyzed via western blot. Results Three compounds were identified a total of 399 targets, GEO revealed a total of 576 CAD-related genes, and 36 overlapping genes of drug-disease were obtained. The PPI network was employed for the analysis of 36 target proteins, including CASP3, mTOR, VEGFA and EGFR. The enrichment analysis demonstrated candidate targets of three compounds were more frequently involved in inflammation, lipid response, oxidative stress, autophagy, apoptosis, diabetic cardiomyopathy and estrogen signaling pathways. In vitro experiments revealed that Sal could induce autophagy in CoCl2-exposed H9C2 cells, significantly reverse cell death in the early period, and decrease the levels of Caspase-3 protein in CoCl2-exposed H9C2 cells. However, Sal-induced autophagy also could promoted the process of CoCl2-exposed H9C2 cells death in the late period. Conclusions This study revealed that Sal existed the effect of treating CAD by regulating multi-targets and multi-channels through the method of network pharmacology. Furthermore, in vitro results confirmed that Sal-induced autophagy played a protective role in the early period of CAD, while aggravated the condition in the late period of CAD.
- 30 November 2022
- Published by Springer Nature in Research Square
Open AccessNetwork pharmacology and in vitro studies show the pharmacological effects and molecular mechanisms of salidroside against coronary artery disease
Background Salidroside (Sal) has many pharmacological effects, including anti-fatigue, anti-aging, immunoregulation and so on. However, its effects and related regulatory mechanisms on coronary artery disease (CAD) are elusive. We hypothesize that Sal may play a role in CAD through autophagic pathway. Herein, we used autophagy agonist (sirolimus, Sir) and inhibitor (chloroquine diphosphate, CQ) as the autophagic control group. And network pharmacology prediction was employed to explore the pharmacological effects and molecular mechanisms of Sal on CAD using network pharmacology prediction, and validated the results through in vitro experiments. Methods Through a search in the Swisstarget Prediction database, chemical composition and targets were retrieved. The related-autophagic targets for CAD were then obtained from the GEO and human autophagy databases. The network was constructed that depicted the interactions between putative drugs (Sal, Sir and CQ) and known related-autophagic targets for CAD using Cytoscape 3.8.0. Analysis of protein-protein interaction (PPI) was achieved via STRING software, followed by gene ontology (GO) functional enrichment and kyoto enrichment of gene and genome (KEGG) pathway analyses. The 3D structure of target protein was downloaded from RSCB PDB database, the 2D structure of drug was obtained from PubChem database, then the molecular docking was constructed by using AutoDockTools 1.5.6 and AutoDock Vina software, and the results were visualized by using PyMoL sofeware. To validate the computer-predicted results, in vitro experiments based on an anoxic injury model were designed by using CoCl2-exposed H9C2 cells, and treated with various concentrations of Sal/Sir/CQ. The effects of drugs on cells were detected by using the CCK-8, inverted microscope (IM), transmission electron microscope (TEM), MDC staining and AO staining. Moreover, the expression profiles of related-proteins were analyzed via western blot. Results Three compounds were identified a total of 399 targets, GEO revealed a total of 576 CAD-related genes, and 36 overlapping genes of drug-disease were obtained. The PPI network was employed for the analysis of 36 target proteins, including CASP3, mTOR, VEGFA and EGFR. The enrichment analysis demonstrated candidate targets of three compounds were more frequently involved in inflammation, lipid response, oxidative stress, autophagy, apoptosis, diabetic cardiomyopathy and estrogen signaling pathways. In vitro experiments revealed that Sal could induce autophagy in CoCl2-exposed H9C2 cells, significantly reverse cell death in the early period, and decrease the levels of Caspase-3 protein in CoCl2-exposed H9C2 cells. However, Sal-induced autophagy also could promoted the process of CoCl2-exposed H9C2 cells death in the late period. Conclusions This study revealed that Sal existed the effect of treating CAD by regulating multi-targets and multi-channels through the method of network pharmacology. Furthermore, in vitro results confirmed that Sal-induced autophagy played a protective role in the early period of CAD, while aggravated the condition in the late period of CAD.